# Optimizing Hoffmann Reflex Rate-Dependent Depression: A Feasible Protocol for Assessing Spinal Inhibition in Upper and Lower Limbs

**Authors:** Andrea S. Ceñal Cisneros, Rodolfo Delgado-Lezama, Carlos A. Cuellar, Oscar Arias-Carrión, Isabel Ruelas Galindo, Mario Vázquez García, Paulina Cervantes Sosa, Luis A. Martínez Zaldívar, Emmanuel Ortega-Robles

PMC · DOI: 10.3390/medsci14010050 · Medical Sciences · 2026-01-19

## TL;DR

This study establishes a reliable and simplified method to assess spinal inhibition using the Hoffmann reflex in both upper and lower limbs of healthy adults.

## Contribution

The study introduces a standardized protocol for measuring rate-dependent depression of the Hoffmann reflex with optimized parameters for clinical use.

## Key findings

- Maximal depression of the Hoffmann reflex occurs at 1–5 Hz, with 1 Hz identified as the optimal frequency.
- Lower limbs showed less depression (~30%) compared to upper limbs (~47%).
- A single seven-pulse train is sufficient for reliable measurements without the need for averaging.

## Abstract

Background: Rate-dependent depression of the Hoffmann reflex (RDD-HR) is a neurophysiological marker of spinal inhibition altered in several neurological conditions, yet no consensus exists on optimal stimulation frequency, number of stimuli, or the feasibility of upper limb recordings. This study aimed to define practical, standardized parameters for reliable RDD-HR assessment in upper and lower limbs of healthy adults, as a first step toward clinical application. Methods: In this observational study, bilateral Hoffmann reflexes were recorded from the flexor carpi radialis and soleus muscles in 21 healthy adults. Stimulation was delivered using three 10-pulse trains at seven frequencies (0.1–5 Hz). RDD-HR was quantified as the median H-reflex area, expressed as a percentage of the first response (lower values indicate greater depression). Optimal frequencies and minimal stimuli were identified by sigmoid fitting and confidence analyses, with train and stimulus effects tested by two-way ANOVA. Results: RDD-HR displayed a sigmoidal frequency–response across all limbs. Maximal depression occurred at 1–5 Hz, with no significant differences between these frequencies, supporting 1 Hz as optimal. Depression was greater in lower limbs (~30%) than upper limbs (~47%). Reliable estimates were obtained using a single train of seven stimuli, with no benefit from averaging across trains. Upper limb recordings required lower stimulation intensities. Conclusions: RDD-HR can be reliably assessed using a simplified protocol based on a single seven-pulse train at two key frequencies. This standardized approach provides a methodological foundation for future clinical validation of RDD-HR as a biomarker of spinal inhibitory dysfunction.

## Full-text entities

- **Diseases:** , and neurological (MESH:D009461), spinal inhibitory dysfunction (MESH:D013122), multiple sclerosis (MESH:D009103), allodynia (MESH:D006930), spinal cord injury (MESH:D013119), neurological and neuropathic disorders (MESH:D009422), post-COVID-19 neurological sequelae (MESH:D000094024), type 1 and type 2 diabetes (MESH:D003924), orthopedic limitations (MESH:D009140), neuropathic conditions (MESH:D009437), Depression (MESH:D003866), obese (MESH:D009765), chronic pain (MESH:D059350), fatigue (MESH:D005221), stroke (MESH:D020521), overweight (MESH:D050177), dementia (MESH:D003704), neurological and psychiatric disorders (MESH:D001523), cardiovascular disease (MESH:D002318), diabetic neuropathy (MESH:D003929), diabetes (MESH:D003920), HR (MESH:D002303), cancer (MESH:D009369), psychosis (MESH:D011618), reflex (MESH:D020195), attention-deficit hyperactivity disorder (MESH:D001289), traumatic brain injury (MESH:D000070642), cerebrovascular disease (MESH:D002561), H-reflex (MESH:D018223), injury to (MESH:D014947), amyotrophic lateral sclerosis (MESH:D000690), fractures (MESH:D050723), pain (MESH:D010146), hypertension (MESH:D006973), upper limb dysfunction (MESH:D038062), dyslipidemia (MESH:D050171), mobility impairments (MESH:D014086), Parkinson's disease (MESH:D010300)
- **Chemicals:** Ag (MESH:D012834), bicuculline (MESH:D001640), isopropyl alcohol (MESH:D019840), AgCl (MESH:C037548), alcohol (MESH:D000438), benzodiazepines (MESH:D001569), caffeine (MESH:D002110)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12922079/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12922079/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12922079/full.md

---
Source: https://tomesphere.com/paper/PMC12922079